Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
Electroconvulsive Therapy (ECT) is a treatment where small electric currents are passed through the brain to help with certain mental conditions. This study is testing if ECT can help calm severe agitation (restlessness) in people with dementia, a condition affecting memory and thinking. Types of dementia include Alzheimer’s Disease, Vascular dementia, Frontotemporal dementia, and Dementia with Lewy Bodies. The study will check if ECT is safe and if it helps in the long term.
Participants need to have a specific type of dementia and meet other health criteria. They must be over 40, understand English, and have someone to give consent for them. The study involves an initial ECT treatment and then a year of follow-up. Importantly, participants should not have certain other mental or health conditions.
- Participants will receive an ECT treatment and be observed for a year.
- 50 people are needed, with some expected to leave early.
- Participants should be prepared for possible risks and side effects of ECT.
Study details
NCT03926520
Brent Forester
22 June 2024
Not finding the right Trial?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
FAQs
Learn more about clinical trials
What is a clinical trial?
Why should I take part in a clinical trial?
How long does a clinical trial take place?
Do I get compensated for taking part in clinical trials?
How safe are clinical trials?
Study Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.